US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ASCENTAGE PHARMA GROUP

17.00

-0.3200-1.85%

Post-market: 17.000.00000.00%19:30 EDT

Volume:2K

Turnover:31.41K

Market Cap:1.59B

PE:-8.61

High:17.44

Open:17.15

Low:17.00

Close:17.32

52wk High:48.45

52wk Low:16.36

Shares:93.33M

Float Shares:71.58M

Volume Ratio:0.19

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.9750

EPS(LYR):-1.9957

ROE:-236.63%

ROA:-28.04%

PB:19.17

PE(LYR):-8.52

Loading ...

Overview Company News Filings

Oppenheimer Keeps Their Buy Rating on Ascentage Pharma Group International Unsponsored ADR (AAPG)

Ascentage Pharma H1 Loss Widens, Revenue Rises

MT Newswires Live

Reported Earlier, Ascentage Pharma Group H1 EPS $(0.32) Beats $(0.44) Estimate, Sales $44.541M Beat $24.070M Estimate

Benzinga Earnings

Ascentage Pharma Reports 2026 Interim Results: Strengthening Commercial Engine and Accelerating Global Expansion

Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates

Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit

Earning Preview: ASCENTAGE PHARMA GROUP this quarter’s revenue is expected to increase by 58.18%, and institutional views are bullish

CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026

Ascentage Pharma appoints Miyara as CBO, Ziegler as CCO

ASCENTAGE PHARMA GROUP Appoints Two Key Executives to Lead Global Business and Commercial Operations

Press Release: Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer

Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026

Ascentage Pharma files to sell American Depositary Shares, no amount given

ASCENTAGE PHARMA Announces Grant of 440,700 Restricted Share Units Under 2021 Plan

Ascentage Pharma announces clinical updates from EHA2026

ASCENTAGE PHARMA GROUP (ASX: 06855) Discloses Multiple Clinical Advances at 2026 European Hematology Association Congress

Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress

ASCENTAGE PHARMA Group Acquires 110,000 Shares for 2022 Restricted Stock Unit Plan

ASCENTAGE PHARMA GROUP Acquires 190,000 Shares Under 2022 Restricted Share Unit Plan

Ascentage Pharma initiated with a Buy at B. Riley

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/AAPG/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AAPG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAPG\",,,,,undefined,":{"symbol":"AAPG","market":"US","secType":"STK","nameCN":"ASCENTAGE PHARMA GROUP","latestPrice":17,"timestamp":1787342400000,"preClose":17.32,"halted":0,"volume":1838,"hourTrading":{"tag":"盘后","latestPrice":17,"preClose":17,"latestTime":"19:30 EDT","volume":42,"amount":715.11,"timestamp":1787355007860,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.018475750577367223,"floatShares":71582800,"shares":93330405,"eps":-1.975,"marketStatus":"Market Closed","change":-0.32,"latestTime":"08-21 16:00:00 EDT","open":17.15,"high":17.4435,"low":17,"amount":31414.382856000004,"amplitude":0.025606,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.975,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":4,"listingDate":1737694800000,"exchange":"NASDAQ","adjPreClose":17.32,"postHourTrading":{"tag":"盘后","latestPrice":17,"preClose":17,"latestTime":"19:30 EDT","volume":42,"amount":715.11,"timestamp":1787355007860,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.19047816661684647},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAPG\",,,,,undefined,":{"symbol":"AAPG","floatShares":71582800,"roa":"-28.04%","roe":"-236.63%","lyrEps":-1.995679,"volumeRatio":0.19047816661684647,"shares":93330405,"dividePrice":0,"high":17.4435,"amplitude":0.025606,"preClose":17.32,"low":17,"week52Low":16.36,"pbRate":"19.17","psRate":"16.59","week52High":48.45,"institutionHeld":0,"latestPrice":17,"eps":-1.975,"divideRate":0,"volume":1838,"delay":0,"ttmEps":-1.975,"open":17.15,"prevYearClose":26.24,"prevWeekClose":19,"prevMonthClose":17.425,"prevQuarterClose":17.56,"fiveDayClose":19,"twentyDayClose":18.29,"sixtyDayClose":20.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AAPG\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"AAPG","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":-0.44,"defaultRemindTime":1787126400000,"name":null,"time":"Pre-MKt","dateTimestamp":1787112000000,"actualEps":null},{"date":"2026-03-25","symbol":"AAPG","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":null,"defaultRemindTime":1774468800000,"name":null,"time":"Post-Mkt","dateTimestamp":1774411200000,"actualEps":null},{"market":"US","date":"2025-08-20","symbol":"AAPG","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755662400000,"reportTimeType":"post","actualEps":null},{"date":"2025-03-27","symbol":"AAPG","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":null,"defaultRemindTime":1743062400000,"name":null,"time":"Pre-MKt","dateTimestamp":1743048000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AAPG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AAPG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2222,"buy":0.7778,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7778,"analysts":9,"updateTime":1781150400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AAPG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AAPG","date":"2026-08-21","current":-8.607595,"percent":1,"low":-76.454813,"twenty":-35.947221,"median":-19.05933,"eighty":-11.591162,"high":-7.057849,"avg":-25.155962,"sd":16.844147,"marketCap":1541157743.83},"quantilePoints":[{"date":"2025-01-31","current":-29.751262,"twenty":-29.75286,"median":-29.751983,"eighty":-29.751262,"marketCap":1478269659.08},{"date":"2025-02-07","current":-32.664532,"twenty":-32.365221,"median":-31.242401,"eighty":-29.752127,"marketCap":1614694688.16},{"date":"2025-02-14","current":-31.1828,"twenty":-32.258438,"median":-31.212601,"eighty":-29.752938,"marketCap":1540476496.81},{"date":"2025-02-21","current":-36.382297,"twenty":-32.721933,"median":-31.802125,"eighty":-29.819279,"marketCap":1806628873.73},{"date":"2025-02-28","current":-33.43308,"twenty":-34.468465,"median":-32.375664,"eighty":-30.230932,"marketCap":1654638501.56},{"date":"2025-03-07","current":-34.452224,"twenty":-34.328072,"median":-32.712367,"eighty":-30.892818,"marketCap":1712841480.27},{"date":"2025-03-14","current":-33.065652,"twenty":-34.096417,"median":-32.760201,"eighty":-31.20664,"marketCap":1644428002.08},{"date":"2025-03-21","current":-32.72391,"twenty":-34.124503,"median":-32.947597,"eighty":-31.448698,"marketCap":1626713850.02},{"date":"2025-03-28","current":-33.955809,"twenty":-34.124503,"median":-33.010704,"eighty":-31.793328,"marketCap":1894714451.86},{"date":"2025-04-04","current":-35.921968,"twenty":-34.855052,"median":-33.21342,"eighty":-31.979778,"marketCap":2000185586.04},{"date":"2025-04-11","current":-29.511221,"twenty":-34.370118,"median":-33.010704,"eighty":-30.892818,"marketCap":1635879540.94},{"date":"2025-04-17","current":-29.520055,"twenty":-34.225935,"median":-32.760201,"eighty":-30.07059,"marketCap":1639709582.7},{"date":"2025-04-25","current":-41.553435,"twenty":-35.045268,"median":-32.920123,"eighty":-30.119556,"marketCap":2311372741.24},{"date":"2025-05-02","current":-38.492689,"twenty":-35.554336,"median":-33.187028,"eighty":-30.682879,"marketCap":2146245101.28},{"date":"2025-05-09","current":-37.35919,"twenty":-36.170996,"median":-33.361942,"eighty":-30.776099,"marketCap":2093177176.92},{"date":"2025-05-16","current":-35.007117,"twenty":-35.955639,"median":-33.43308,"eighty":-31.102567,"marketCap":1969122395.28},{"date":"2025-05-23","current":-39.338512,"twenty":-36.352488,"median":-33.608398,"eighty":-31.19472,"marketCap":2213435510.22},{"date":"2025-05-30","current":-38.856398,"twenty":-37.35919,"median":-33.992043,"eighty":-31.242401,"marketCap":2192363417.29},{"date":"2025-06-06","current":-42.814884,"twenty":-37.865895,"median":-34.141844,"eighty":-31.758144,"marketCap":2419987007.19},{"date":"2025-06-13","current":-48.171029,"twenty":-38.492689,"median":-34.477812,"eighty":-31.846105,"marketCap":2722575737.57},{"date":"2025-06-20","current":-55.929302,"twenty":-38.862859,"median":-34.635358,"eighty":-32.113451,"marketCap":3154688383.5},{"date":"2025-06-27","current":-59.787237,"twenty":-39.399619,"median":-35.123604,"eighty":-32.336589,"marketCap":3381751544.24},{"date":"2025-07-03","current":-64.068526,"twenty":-41.436089,"median":-35.258863,"eighty":-32.429915,"marketCap":3624015684.35},{"date":"2025-07-11","current":-59.084566,"twenty":-43.897892,"median":-35.501693,"eighty":-32.48435,"marketCap":3338745741.38},{"date":"2025-07-18","current":-61.880278,"twenty":-48.308604,"median":-35.791073,"eighty":-32.545465,"marketCap":3494679880.36},{"date":"2025-07-25","current":-58.315576,"twenty":-54.849764,"median":-35.921968,"eighty":-32.616809,"marketCap":3304687864.64},{"date":"2025-08-01","current":-60.559654,"twenty":-57.422661,"median":-36.233253,"eighty":-32.655768,"marketCap":3410643633.03},{"date":"2025-08-08","current":-69.260076,"twenty":-59.023969,"median":-36.597865,"eighty":-32.679287,"marketCap":3910472388.03},{"date":"2025-08-15","current":-72.346957,"twenty":-59.602544,"median":-37.391167,"eighty":-32.709995,"marketCap":4086922647.44},{"date":"2025-08-22","current":-26.724459,"twenty":-60.097702,"median":-37.493155,"eighty":-32.679287,"marketCap":4314209810.62},{"date":"2025-08-29","current":-24.396919,"twenty":-59.865528,"median":-36.699167,"eighty":-32.48435,"marketCap":3966417985.85},{"date":"2025-09-05","current":-22.946281,"twenty":-59.664109,"median":-36.382297,"eighty":-31.979778,"marketCap":3724203040.4},{"date":"2025-09-12","current":-22.941741,"twenty":-59.475774,"median":-35.943012,"eighty":-31.122625,"marketCap":3735810338.07},{"date":"2025-09-19","current":-21.785524,"twenty":-59.316014,"median":-35.857966,"eighty":-29.943039,"marketCap":3550375801.58},{"date":"2025-09-26","current":-21.102028,"twenty":-59.062646,"median":-35.66937,"eighty":-29.751262,"marketCap":3428719452.06},{"date":"2025-10-03","current":-22.266298,"twenty":-59.025902,"median":-35.30284,"eighty":-28.699054,"marketCap":3625414266.5},{"date":"2025-10-10","current":-21.050291,"twenty":-58.738293,"median":-35.189473,"eighty":-26.732175,"marketCap":3423480133.18},{"date":"2025-10-17","current":-19.80269,"twenty":-58.191808,"median":-34.731922,"eighty":-24.468638,"marketCap":3221889328.22},{"date":"2025-10-24","current":-19.801335,"twenty":-57.904825,"median":-34.477812,"eighty":-23.569995,"marketCap":3222890223.42},{"date":"2025-10-31","current":-19.321494,"twenty":-57.532716,"median":-34.141844,"eighty":-22.943557,"marketCap":3150231208.59},{"date":"2025-11-07","current":-18.112503,"twenty":-56.69325,"median":-33.992043,"eighty":-22.558349,"marketCap":2949090425.48},{"date":"2025-11-14","current":-19.583345,"twenty":-55.920234,"median":-33.485756,"eighty":-22.342071,"marketCap":3199584585.23},{"date":"2025-11-21","current":-17.547753,"twenty":-55.765092,"median":-33.408485,"eighty":-22.122489,"marketCap":2860955000.96},{"date":"2025-11-28","current":-18.539078,"twenty":-55.318442,"median":-33.361942,"eighty":-21.796498,"marketCap":3034915066.08},{"date":"2025-12-05","current":-18.33416,"twenty":-53.27811,"median":-33.187028,"eighty":-21.590149,"marketCap":3005486168.49},{"date":"2025-12-12","current":-17.062052,"twenty":-48.796704,"median":-32.920123,"eighty":-21.073758,"marketCap":2802301628.68},{"date":"2025-12-19","current":-16.188794,"twenty":-48.517949,"median":-32.72391,"eighty":-20.125041,"marketCap":2665447409.6},{"date":"2025-12-26","current":-15.347054,"twenty":-48.514967,"median":-32.664532,"eighty":-19.801335,"marketCap":2537308174.25},{"date":"2026-01-02","current":-14.520508,"twenty":-48.239817,"median":-32.57809,"eighty":-19.656119,"marketCap":2406972911.39},{"date":"2026-01-09","current":-15.636938,"twenty":-46.480698,"median":-32.420873,"eighty":-19.300607,"marketCap":2595562368.02},{"date":"2026-01-16","current":-14.792082,"twenty":-45.997596,"median":-31.846105,"eighty":-19.073232,"marketCap":2461528990.12},{"date":"2026-01-23","current":-14.451393,"twenty":-45.706429,"median":-31.242401,"eighty":-18.892753,"marketCap":2402559084.95},{"date":"2026-01-30","current":-13.594278,"twenty":-43.897892,"median":-30.891003,"eighty":-18.486342,"marketCap":2268064814.82},{"date":"2026-02-06","current":-13.215954,"twenty":-42.7913,"median":-29.979764,"eighty":-18.329609,"marketCap":2208187061.91},{"date":"2026-02-13","current":-13.314281,"twenty":-42.590497,"median":-29.752899,"eighty":-18.136415,"marketCap":2236446544.83},{"date":"2026-02-20","current":-13.322258,"twenty":-42.10164,"median":-29.751262,"eighty":-17.934704,"marketCap":2235292402.77},{"date":"2026-02-27","current":-13.022247,"twenty":-41.475205,"median":-29.511221,"eighty":-17.157024,"marketCap":2206480506.48},{"date":"2026-03-06","current":-12.669019,"twenty":-41.161756,"median":-28.176938,"eighty":-16.734267,"marketCap":2131116747.44},{"date":"2026-03-13","current":-12.688953,"twenty":-40.378179,"median":-26.74375,"eighty":-16.137082,"marketCap":2141399622.46},{"date":"2026-03-20","current":-11.937263,"twenty":-39.521832,"median":-25.944924,"eighty":-15.566094,"marketCap":2005434649.33},{"date":"2026-03-27","current":-12.020857,"twenty":-39.289753,"median":-24.396919,"eighty":-15.439715,"marketCap":2161491459.44},{"date":"2026-04-02","current":-13.548587,"twenty":-39.152841,"median":-23.731199,"eighty":-15.186721,"marketCap":2444436047.79},{"date":"2026-04-10","current":-12.693217,"twenty":-38.895939,"median":-23.387346,"eighty":-14.745986,"marketCap":2308441702.51},{"date":"2026-04-17","current":-13.620079,"twenty":-38.882244,"median":-22.946281,"eighty":-14.465216,"marketCap":2481253103.51},{"date":"2026-04-24","current":-12.083101,"twenty":-38.84865,"median":-22.780777,"eighty":-14.008358,"marketCap":2199221373.05},{"date":"2026-05-01","current":-11.527627,"twenty":-38.758432,"median":-22.499202,"eighty":-13.791914,"marketCap":2098243441.9},{"date":"2026-05-08","current":-10.968155,"twenty":-38.515761,"median":-22.389807,"eighty":-13.684651,"marketCap":2004129088.99},{"date":"2026-05-15","current":-10.082774,"twenty":-38.444183,"median":-22.266298,"eighty":-13.539734,"marketCap":1846775928.57},{"date":"2026-05-22","current":-10.707594,"twenty":-38.225934,"median":-22.137659,"eighty":-13.395768,"marketCap":1956144727.44},{"date":"2026-05-29","current":-10.055476,"twenty":-38.129026,"median":-21.923528,"eighty":-13.314281,"marketCap":1843351578.24},{"date":"2026-06-05","current":-8.909894,"twenty":-37.937734,"median":-21.785524,"eighty":-13.216389,"marketCap":1635661877.38},{"date":"2026-06-12","current":-8.93641,"twenty":-37.865895,"median":-21.603031,"eighty":-13.157057,"marketCap":1639076784.73},{"date":"2026-06-18","current":-8.353042,"twenty":-37.752402,"median":-21.278471,"eighty":-13.101714,"marketCap":1535636323.4},{"date":"2026-06-26","current":-7.824164,"twenty":-37.62092,"median":-21.066691,"eighty":-13.023474,"marketCap":1430786980.62},{"date":"2026-07-02","current":-8.952074,"twenty":-37.472757,"median":-20.67449,"eighty":-12.989985,"marketCap":1637864621.41},{"date":"2026-07-10","current":-9.338033,"twenty":-37.371981,"median":-19.946515,"eighty":-12.776282,"marketCap":1707700089.2},{"date":"2026-07-17","current":-9.151372,"twenty":-36.963176,"median":-19.801335,"eighty":-12.672971,"marketCap":1678950333.06},{"date":"2026-07-24","current":-9.04646,"twenty":-36.577605,"median":-19.676085,"eighty":-12.361815,"marketCap":1659751775.25},{"date":"2026-07-31","current":-8.626077,"twenty":-36.450857,"median":-19.539859,"eighty":-12.179575,"marketCap":1585151449.4},{"date":"2026-08-07","current":-9.281807,"twenty":-36.322679,"median":-19.321494,"eighty":-11.987055,"marketCap":1708580872.07},{"date":"2026-08-14","current":-9.158138,"twenty":-36.125575,"median":-19.172925,"eighty":-11.879713,"marketCap":1687515849.52},{"date":"2026-08-21","current":-7.057849,"twenty":-35.947221,"median":-19.05933,"eighty":-11.591162,"marketCap":1541157743.83}],"updateTime":1787499543346},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AAPG\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661260487","title":"Oppenheimer Keeps Their Buy Rating on Ascentage Pharma Group International Unsponsored ADR (AAPG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260487","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260487?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:55","pubTimestamp":1787313347,"startTime":"0","endTime":"0","summary":"Oppenheimer analyst Jeff Jones maintained a Buy rating on Ascentage Pharma Group International Unsponsored ADR today and set a price target of $45....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-keeps-their-buy-rating-on-ascentage-pharma-group-international-unsponsored-adr-aapg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-keeps-their-buy-rating-on-ascentage-pharma-group-international-unsponsored-adr-aapg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SAPH","OPY","APIE","ARMH","DIVL","AAPG","AADR","DINT","CVY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660401977","title":"Ascentage Pharma H1 Loss Widens, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2660401977","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660401977?lang=en_us&edition=fundamental","pubTime":"2026-08-20 15:28","pubTimestamp":1787210936,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group  reported an H1 loss Wednesday of 2.19 Chinese renminbi  per diluted share, widening from a loss of 1.73 renminbi a year earlier.Revenue for the half-year ended June 30 was 302.2 million renminbi, up from 233.7 million renminbi a year earlier.Shares of the company were down more than 2% in Thursday premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CWEB","KCAI","02822","KGRN","YINN","AAPG","02843","YANG","82822","ASHS","ASHR","02823","YXI","82843","XPP","BK4139","FLCH","KWEB","FXP","CHAU","82823"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660529406","title":"Reported Earlier, Ascentage Pharma Group H1 EPS $(0.32) Beats $(0.44) Estimate, Sales $44.541M Beat $24.070M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2660529406","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660529406?lang=en_us&edition=fundamental","pubTime":"2026-08-20 14:18","pubTimestamp":1787206735,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group (NASDAQ:AAPG) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.44) by 27.27 percent. This is a 33.33 percent decrease over losses of $(0.24) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61320938/reported-earlier-ascentage-pharma-group-h1-eps-0-32-beats-0-44-estimate-sales-44-541m-beat-24-070m-e","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199487193","title":"Ascentage Pharma Reports 2026 Interim Results: Strengthening Commercial Engine and Accelerating Global Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1199487193","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199487193?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:40","pubTimestamp":1787182818,"startTime":"0","endTime":"0","summary":"Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855) has announced its interim results for the first half of 2026, showcasing continued momentum in its commercial operations. Total revenue for the period...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4139","BK1574","06855","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660471837","title":"Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2660471837","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660471837?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:00","pubTimestamp":1787180400,"startTime":"0","endTime":"0","summary":"Revenue for the first half of 2026 increased29% year-over-year to US$44.5 million (RMB302.2 million), primarily attributable to increased product sales. Expanded executive leadership with appointments","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/19/3348052/0/en/ascentage-pharma-reports-2026-interim-unaudited-financial-results-and-provides-business-updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DTP","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659615457","title":"Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2659615457","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659615457?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:00","pubTimestamp":1786622400,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md., Aug.  13, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biophar","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/13/3344461/0/en/ascentage-pharma-to-participate-in-the-evercore-2nd-annual-china-biotech-summit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","AAPG","BK4581","XBI","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158593007","title":"Earning Preview: ASCENTAGE PHARMA GROUP this quarter’s revenue is expected to increase by 58.18%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1158593007","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158593007?lang=en_us&edition=fundamental","pubTime":"2026-08-12 11:51","pubTimestamp":1786506676,"startTime":"0","endTime":"0","summary":"Abstract ASCENTAGE PHARMA GROUP is scheduled to release quarterly results on August 19, 2026 Pre-Mkt, and consensus points to faster top-line growth with narrowing per-share losses as its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: ASCENTAGE PHARMA GROUP this quarter’s revenue is expected to increase by 58.18%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657547113","title":"CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2657547113","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657547113?lang=en_us&edition=fundamental","pubTime":"2026-08-05 21:07","pubTimestamp":1785935220,"startTime":"0","endTime":"0","summary":"In a release issued under the same headline earlier today by Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855),please note that in the first paragraph of the release, the time should be ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/05/3339389/0/en/CORRECTION-Ascentage-Pharma-to-Report-2026-Six-Month-Interim-Results-and-Provide-Corporate-Update-on-August-19-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656102346","title":"Ascentage Pharma appoints Miyara as CBO, Ziegler as CCO","url":"https://stock-news.laohu8.com/highlight/detail?id=2656102346","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656102346?lang=en_us&edition=fundamental","pubTime":"2026-08-03 08:00","pubTimestamp":1785715214,"startTime":"0","endTime":"0","summary":"Ascentage Pharma (AAPG) Group announced the appointment of Faical Miyara, PhD, as Chief Business Officer, CBO, responsible for the Company’s global...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ascentage-pharma-appoints-miyara-as-cbo-ziegler-as-cco-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ascentage-pharma-appoints-miyara-as-cbo-ziegler-as-cco-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2294711713.HKD","LU2357125470.USD","LU0823414478.USD","LU2249611893.SGD","AAPG","BK4139","CCO","LU0823414551.USD","BK4009","LU2506951792.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177768322","title":"ASCENTAGE PHARMA GROUP Appoints Two Key Executives to Lead Global Business and Commercial Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=1177768322","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177768322?lang=en_us&edition=fundamental","pubTime":"2026-08-03 07:40","pubTimestamp":1785714027,"startTime":"0","endTime":"0","summary":"ASCENTAGE PHARMA GROUP (06855) announced the appointment of Dr. Faiçal Miyara as Chief Business Officer (CBO) and Jim Ziegler as Chief Commercial Officer (CCO), effective immediately.Dr. Miyara will...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPG","BK1161","06855","BK1574","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656468243","title":"Press Release: Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2656468243","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656468243?lang=en_us&edition=fundamental","pubTime":"2026-08-03 07:30","pubTimestamp":1785713400,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md., Aug. 02, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company engaged in the disco","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU2294711713.HKD","BK4022","06855","BK4232","LU2357125470.USD","LU0823414478.USD","LU2249611893.SGD","AAPG","BK4139","R","CCO","LU0823414551.USD","BK1574","BK4009","LU2506951792.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654206030","title":"Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2654206030","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654206030?lang=en_us&edition=fundamental","pubTime":"2026-07-27 07:30","pubTimestamp":1785108600,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md. and SUZHOU, China, July  26, 2026  (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/26/3333236/0/en/Ascentage-Pharma-Chairman-and-CEO-Dr-Dajun-Yang-Named-to-The-Medicine-Maker-Power-List-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","PW","BK4084","EMA","BK4139","BK4234","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652292690","title":"Ascentage Pharma files to sell American Depositary Shares, no amount given","url":"https://stock-news.laohu8.com/highlight/detail?id=2652292690","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652292690?lang=en_us&edition=fundamental","pubTime":"2026-07-20 18:05","pubTimestamp":1784541905,"startTime":"0","endTime":"0","summary":"06:04 EDT Ascentage Pharma (AAPG) files to sell American Depositary Shares, no amount given Published first on TheFly – the ultimate source for rea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ascentage-pharma-files-to-sell-american-depositary-shares-no-amount-given-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ascentage-pharma-files-to-sell-american-depositary-shares-no-amount-given-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4107","AFG","AAPG","BK4139","BK4117"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191240067","title":"ASCENTAGE PHARMA Announces Grant of 440,700 Restricted Share Units Under 2021 Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1191240067","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191240067?lang=en_us&edition=fundamental","pubTime":"2026-06-30 08:56","pubTimestamp":1782780989,"startTime":"0","endTime":"0","summary":"ASCENTAGE PHARMA GROUP (HKEX: 06855) has announced the issuance of new restricted share units. According to the company's filing, a total of 440,700 restricted share units were granted under its 2021...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","06855","AAPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643422806","title":"Ascentage Pharma announces clinical updates from EHA2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643422806","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643422806?lang=en_us&edition=fundamental","pubTime":"2026-06-15 07:50","pubTimestamp":1781481005,"startTime":"0","endTime":"0","summary":"Ascentage Pharma (AAPG) announced that seventeen clinical updates from its core assets were presented at the 31st Congress of the European Hematolo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ascentage-pharma-announces-clinical-updates-from-eha2026-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ascentage-pharma-announces-clinical-updates-from-eha2026-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EPV","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155334240","title":"ASCENTAGE PHARMA GROUP (ASX: 06855) Discloses Multiple Clinical Advances at 2026 European Hematology Association Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=1155334240","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155334240?lang=en_us&edition=fundamental","pubTime":"2026-06-15 07:34","pubTimestamp":1781480073,"startTime":"0","endTime":"0","summary":"ASCENTAGE PHARMA GROUP (ASX: 06855) has announced that significant clinical progress for its core products was presented at the 2026 European Hematology Association (EHA) Congress, featuring a total...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","06855","BK1161","AAPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643228204","title":"Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2643228204","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643228204?lang=en_us&edition=fundamental","pubTime":"2026-06-15 07:30","pubTimestamp":1781479800,"startTime":"0","endTime":"0","summary":"Poster presentations from ongoing clinical trials of two core assets, olverembatinib and lisaftoclax, highlight global innovation capabilities in hematologic malignancies ROCKVILLE, Md. and SUZHOU, Ch","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/14/3311475/0/en/Ascentage-Pharma-Presents-Multiple-Clinical-Updates-at-EHA2026-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORR","CSF","BK4139","PFS","AAPG","BK4211","BK4195"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173276790","title":"ASCENTAGE PHARMA Group Acquires 110,000 Shares for 2022 Restricted Stock Unit Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1173276790","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173276790?lang=en_us&edition=fundamental","pubTime":"2026-06-11 21:34","pubTimestamp":1781184855,"startTime":"0","endTime":"0","summary":"The trustee for ASCENTAGE PHARMA GROUP (ASX: AAPG) has purchased a total of 110,000 existing shares on the market.This transaction, conducted on June 11, 2026, was executed to fulfill obligations under the company's 2022 Restricted Stock Unit Plan upon the vesting of those units.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4139","BK1161","06855","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143163354","title":"ASCENTAGE PHARMA GROUP Acquires 190,000 Shares Under 2022 Restricted Share Unit Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1143163354","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143163354?lang=en_us&edition=fundamental","pubTime":"2026-06-10 20:58","pubTimestamp":1781096295,"startTime":"0","endTime":"0","summary":"On June 10, 2026, the trustee purchased a total of 190,000 existing shares on the market. This acquisition was made for the purpose of the 2022 Restricted Share Unit Plan, to fulfill obligations upon the vesting of restricted share units.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06855","BK1574","AAPG","BK1161","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642426654","title":"Ascentage Pharma initiated with a Buy at B. Riley","url":"https://stock-news.laohu8.com/highlight/detail?id=2642426654","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642426654?lang=en_us&edition=fundamental","pubTime":"2026-06-10 20:29","pubTimestamp":1781094582,"startTime":"0","endTime":"0","summary":"B. Riley initiated coverage of Ascentage Pharma (AAPG) with a Buy rating and $45 price target The company has two drugs approved and selling in Chi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ascentage-pharma-initiated-with-a-buy-at-b-riley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ascentage-pharma-initiated-with-a-buy-at-b-riley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AAPG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":56,"code":"91000000","status":"200"}]}}